Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: A study of ARIC and 1000 genome cohorts

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhou, Zhou ^a   Yu, Fuli ^b,c   Buchanan, Ashley ^d   Fu, Yuanyuan ^a   Campos, Marco ^b   Wu, Kenneth K ^e   Chambless, Lloyd E ^d   Folsom, Aaron R ^f   Boerwinkle, Eric ^g   Dong, Jing Fei ^h,i  

^a FUWAI HOSPITAL   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d IL   (United States)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^h PUGET SOUND BLOOD CENTER   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR ANTIGEN;

AFRICAN AMERICAN; ARTICLE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MALE; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VON WILLEBRAND FACTOR GENE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; COHORT STUDIES; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOME, HUMAN; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS; VON WILLEBRAND FACTOR;

EID: 84898459717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084810     Document Type: Article

References (26)

1. Franchini M, Mannucci PM (2008) Von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemos. 34:663-669.
2. Franchini M, Lippi G (2006) Von Willebrand factor and thrombosis. Ann. Hematol. 85:415-423. (Pubitemid 44283106)
3. Pareti F, Lattuada A, Bressi C, Zanobini M, Sala A, et al. (2000) Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 102:1290-1295.
4. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96:1102-1108. (Pubitemid 27344210)
5. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, et al. (2004) Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 109:1343-1348. (Pubitemid 38387818)
6. Goodeve AC (2010) The genetic basis of von Willebrand disease. Blood Rev 24:123-134.
7. Folsom AR, Wu KK, Conlan MG, Finch A, Davis CE, et al. (1992) Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis 2:35-46.
8. Green D, Ruth KJ, Folsom AR, Liu K (1994) Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb 14:686-693.
9. Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, et al. (2006) High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 37:2672-2677. (Pubitemid 44922524)
10. Vischer UM, Wollheim CB (1998) Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis. Blood 91:118-127. (Pubitemid 28018735)
11. Souto JC, Almasy L, Muniz-Diaz E, Soria JM, Borrell M, et al. (2000) Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 20:2024-2028. (Pubitemid 30644654)
12. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, and Montgomery RR. (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691-1695. (Pubitemid 17091627)
13. Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, et al. (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68:236-240.
14. Lacquemant C, Gaucher C, Delorme C, Chatellier G, Gallois Y, et al. (2000) Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. Kidney Int 57:1437-1443. (Pubitemid 30207903)
15. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D (1999) Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 93:4277-4283. (Pubitemid 29279270)
16. Campos M, Sun W, Yu F, Barbalic M, Tang W, et al. (2011) Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort. Blood 117:5224-5230.
17. Wang QY, Song J, Gibbs RA, Boerwinkle E, Dong JF, and Yu FL (2013) Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes. J Thromb Haemos. 11:261-269.
18. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, et al. (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380-385. (Pubitemid 23254660)
19. Bellissimo DB, Christopherson PA, Flood VH, Gill JC, Friedman KD, et al. (2012). VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population. Blood 119:2135-2140.
20. Johnsen JM, Auer PL, Morrison AC, Jiao S, Wei P, et al. (2013) Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood 122:590-597.
21. The ARIC investigators (1989) The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 129:687-702.
22. Campos M, Buchanan A, Yu F, Barbalic M, Xiao Y, et al. (2012) Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. Blood 119:1929-1934.
23. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. (2001) Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 67:125-129.
24. Verweij CL, Hart M, Pannekoek H. (1987) Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the propolypeptide in vWF multimer formation. EMBO J 6:2885-2890.
25. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D. (1987) Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 70:1679-1682. (Pubitemid 18026187)
26. Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, et al. (2010) Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 121:1382-1392.